Breast Cancer and Multiple MyelomaFrequency Distribution of Antineoplastic Regimens (010) (2)

Patients, n (%)

ZOMETAŽ ZOMETA Pam

No. of 4 mg 8/4 mg 90 mg

Stratum regimen N = 563 N = 524 N = 556

37

Breast cancer with

chemotherapy, n 176 169 179

0 3 (1.7) 5 (3.0) 6 (3.4)

1 53 (30.1) 51 (30.2) 58 (32.4)

2 61 (34.7) 65 (38.5) 56 (31.3)

3 34 (19.3) 22 (13.0) 35 (19.6)

4 11 (6.3) 17 (10.1) 16 (8.9)

? 5 14 (8.0) 9 (5.3) 8 (4.5)

Breast cancer with

hormonal therapy, n 201 195 210

0 3 (1.5) 1 (0.5) 3 (1.4)

1 93 (46.3) 114 (58.5) 91 (43.3)

2 59 (29.4) 48 (24.6) 69 (32.9)

3 32 (15.9) 19 (9.7) 34 (16.2)

4 7 (3.5) 7 (3.6) 8 (3.8)

? 5 7 (3.5) 6 (3.1) 5 (2.4)

PTT 8.2-7

Previous slide

Next slide

Back to first slide

View graphic version